Organogenesis Holdings Inc. held its 2025 Annual Meeting of Stockholders on June 23, 2025. During the meeting, stockholders approved several proposals. These included the re-election of Garrett Lustig to the board of directors, the issuance of over 20% of outstanding Class A common stock upon conversion of Series A Convertible Preferred Stock, and the election of directors Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf, and Gilberto Quintero. All proposals were approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organogenesis Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-145767), on June 24, 2025, and is solely responsible for the information contained therein.